Literature DB >> 17287077

Application and interpretation of FISH in biomarker studies.

Jane Bayani1, Jeremy A Squire.   

Abstract

Emerging genomic and proteomic data is creating new opportunities to identify novel biomarkers that will have pathway-specific therapeutic impact on cancer progression. Molecular cytogenetic and fluorescence in situ hybridization (FISH) methods have been primarily used in discovery genetic research laboratories until recently. New automated analytical platforms based on FISH technologies and tissue microarray methods are providing a rapid means to determine the impact of consistent genomic aberrations in clinical trials, and in studies designed to investigate differential chemotherapeutic response.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17287077     DOI： 10.1016/j.canlet.2006.12.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  8 in total

1.  Quantitative analysis of centromeric FISH spots during the cell cycle by image cytometry.

Authors:  Genta Amakawa; Kenzo Ikemoto; Hideaki Ito; Tomoko Furuya; Kohsuke Sasaki
Journal:  J Histochem Cytochem       Date:  2013-07-04       Impact factor: 2.479

2.  Application of Nucleic Acid Mimics in Fluorescence In Situ Hybridization.

Authors:  Ricardo Oliveira; Andreia S Azevedo; Luzia Mendes
Journal:  Methods Mol Biol       Date:  2021

3.  Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer.

Authors:  Baihong Guo; Tuanjie Che; Baoguang Shi; Lijun Guo; Zhihua Zhang; Lin Li; Chuanyong Cai; Yirong Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray.

Authors:  Baihong Guo; Tuanjie Che; Baoguang Shi; Lijun Guo; Yongsheng Yin; Lin Li; Jinming Wang; Dongwen Yan; Yirong Chen
Journal:  Can Urol Assoc J       Date:  2011-01-13       Impact factor: 1.862

5.  Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.

Authors:  Shih-Chiang Huang; Lei Zhang; Yun-Shao Sung; Chun-Liang Chen; Yu-Chien Kao; Narasimhan P Agaram; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2016-06-24       Impact factor: 5.006

Review 6.  Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.

Authors:  Ismail El-Mokadem; John Fitzpatrick; Bhavan Rai; J Cunningham; Norman Pratt; Stewart Fleming; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

7.  Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.

Authors:  I El-Mokadem; J Fitzpatrick; J Bondad; P Rauchhaus; J Cunningham; N Pratt; S Fleming; G Nabi
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

8.  DNA mimics for the rapid identification of microorganisms by fluorescence in situ hybridization (FISH).

Authors:  Laura Cerqueira; Nuno F Azevedo; Carina Almeida; Tatiana Jardim; Charles William Keevil; Maria J Vieira
Journal:  Int J Mol Sci       Date:  2008-10-20       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.